Lumasiran Safe, Effective Long-Term for Primary Hyperoxaluria Type 1
Investigators report sustained reductions in urinary and plasma oxalate through 24 months of lumasiran treatment.
National Kidney Foundation Annual Meeting
RAASi Dose Reduction, Discontinuation in CKD Common After Hyperkalemia
In a study of patients with CKD and/or heart failure on RAASi therapy, the proportion of patients who received dose reductions or had therapy discontinued after new-onset hyperkalemia increased with hyperkalemia severity.
Real-World Phosphate Binder Use Described
Nearly two-thirds of patients receiving dialysis use phosphate binders intermittently, a study found.
Nephrotoxic Drugs ID’d as Sole Risk Factor for AKI Requiring RRT
Two-thirds of studied patients were exposed to nephrotoxic medications, which was identified as a risk factor for RRT initiation.
Kidney Stone Type Shown to Differ by CKD Stage
Kidney stone risk factors and composition vary according to renal function in patients with chronic kidney disease.
In AKI-ARDS, Gender, CRRT Do Not Affect In-Hospital Mortality
Hospital length of stay, however, is significantly longer for women than men.
Elevated Pre-Kidney Transplant Sodium Level May Hike Death Risk
The mechanism by which pre-transplant hypernatremia leads to post-transplant mortality is currently unclear.
Implications of Value-Based Models in Kidney Care
The “Advancing American Kidney Health Initiative” aims to reduce the ESRD rate by 25% by 2030.
Women Have Less Access to Kidney Transplant Waitlist
Interventions may be needed to achieve gender and racial equity in access to kidney transplantation across end-stage renal disease networks in the United States.
Preemptive Therapy May Stop FSGS Recurrence in Kidney Transplant Recipients
Investigators report encouraging results from a small observational study testing the effect of preemptive therapeutic plasma exchange and rituximab in kidney transplant recipients whose primary cause of kidney failure was focal segmental glomerulosclerosis.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in NKF 2021 Spring Meeting
Loading... 
Loading...